Literature DB >> 15708599

SU proteins from virulent and avirulent EIAV demonstrate distinct biological properties.

J M Ball1, C L Swaggerty, X Pei, W S Lim, X Xu, V C Cox, S L Payne.   

Abstract

Biologic activity of equine infectious anemia virus (EIAV) surface (SU) glycoprotein was assayed in a mouse model. Recombinant SU from virulent EIAV17 (SU17), administered intraperitoneally to mouse pups, induced dose-dependent diarrheal responses similar to those reported for SIV SU (Virology 277 (2000) 250). SU17 caused fluid accumulation without histological lesions in mouse intestinal loops, induced chloride secretory currents in Ussing chambers and increased inositol 1,4,5 triphosphate (IP3) levels in HT29 cells. An SU17 peptide, SU17(299-330), provoked a dose-dependent diarrheal response akin to enterotoxic peptides from SIV. In contrast, SU from an avirulent EIAV strain failed to induce a dose response in mouse pups and produced lower levels of activity than SU17 in Ussing chambers and IP3 assays. These results demonstrate that a mouse pup model is useful to monitor EIAV SU biologic activity, showing clear differences between the activities of SU derived from virulent and avirulent viruses, and may provide a useful screen of EIAV virulence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15708599     DOI: 10.1016/j.virol.2004.12.022

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  1 in total

1.  Genetic Evolution during the development of an attenuated EIAV vaccine.

Authors:  Xue-Feng Wang; Yue-Zhi Lin; Qiang Li; Qiang Liu; Wei-Wei Zhao; Cheng Du; Jie Chen; Xiaojun Wang; Jian-Hua Zhou
Journal:  Retrovirology       Date:  2016-02-03       Impact factor: 4.602

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.